Market closedNon-fractionalADR
Dr. Reddy's Laboratories/RDY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Dr. Reddy's Laboratories
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).
Ticker
RDY
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology & Drugs
Headquarters
Hyderabad, India
Employees
25,863
Website
www.drreddys.com
RDY Metrics
BasicAdvanced
$12B
Market cap
17.15
P/E ratio
$4.00
EPS
0.52
Beta
$0.48
Dividend rate
0.70%
Dividend yield
Price and volume
Market cap
$12B
Beta
0.52
52-week high
$77.72
52-week low
$56.04
Average daily volume
4.6
Dividend rate
$0.48
Financial strength
Current ratio
2.583
Quick ratio
1.921
Long term debt to equity
2.135
Total debt to equity
7.136
Dividend payout ratio (TTM)
12.01%
Enterprise value to free cash flow
16.716
Management effectiveness
Return on assets (TTM)
15.70%
Return on equity (TTM)
21.77%
Return on investment (TTM)
21.11%
Valuation
Price to earnings (TTM)
17.153
Price to revenue (TTM)
3.461
Price to book
3.401
Price to tangible book (TTM)
4.037
Price to free cash flow (TTM)
33.282
Five year average dividend yield
0.63%
Dividend yield (TTM)
0.70%
Forward dividend yield
0.70%
Growth
Revenue change (TTM)
13.54%
Earnings per share change (TTM)
23.32%
3-year revenue growth (CAGR)
13.74%
3-year earnings per share growth (CAGR)
47.71%
3-year dividend per share growth (CAGR)
18.00%
What the Analysts think about RDY
Analyst Ratings
Majority rating from 3 analysts.
RDY Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
₹71B
-1.83%
Net income
₹13B
-5.21%
Profit margin
18.45%
-3.45%
RDY Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
₹84.36
₹88.91
₹82.81
₹78.35
-
Expected
₹57.03
₹69.65
₹70.43
₹68.45
₹76.07
Surprise
47.93%
27.65%
17.58%
14.47%
-
RDY News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractionalADR
Upcoming events
Jul
30
Dr. Reddy's Laboratories
Dividend·Ex-dividend
FAQs
What’s the current market cap for Dr. Reddy's Laboratories stock?
Dr. Reddy's Laboratories (RDY) has a market cap of $12B as of July 26, 2024.
What is the P/E ratio for Dr. Reddy's Laboratories stock?
The price to earnings (P/E) ratio for Dr. Reddy's Laboratories (RDY) stock is 17.15 as of July 26, 2024.
Does Dr. Reddy's Laboratories stock pay dividends?
Yes, the Dr. Reddy's Laboratories (RDY) stock pays dividends to shareholders. As of July 26, 2024, the dividend rate is $0.48126 and the yield is 0.7%. Dr. Reddy's Laboratories has a payout ratio of 12.01% on a trailing twelve-month basis.
When is the next Dr. Reddy's Laboratories dividend payment date?
The next Dr. Reddy's Laboratories (RDY) dividend payment date is unconfirmed.
What is the beta indicator for Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories (RDY) has a beta rating of 0.52. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Dr. Reddy's Laboratories stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.